Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Australia

 

Health care service write-offs drive losses at Bupa

Bupa, the global healthcare insurer and healthcare operator went from pre-tax profits of £502m in 2018 to a loss of £78m in 2019, thanks mainly to huge write-offs in its UK dentistry business and Australian care homes. But stripping out write-offs, underlying profitability still plunged 31%. Revenue rose just 4%. Why, and what does this tell us about Bupa and its future?

Big teleradiology provider for sale as sector hots up

London-listed investment firm ICG is reportedly selling its UK-Australia teleradiology platform Everlight Radiology, while a Spanish diagnostics group recently entered the Latin American market with a small deal. The deals show two of the four cross-border teleradiology streams we have identified.

Interview: Julian Andriesz, CEO, Verita Healthcare

The massive latent demand to live longer is being tapped by a new generation of health care providers. British entrepreneur Julian Andriesz, 53, made a first fortune building business in SE Asia and got into prevention after watching his mother die of ovarian cancer, diagnosed late. He says his intention is to help his clients, whether they are healthy, have cancer or auto-immune diseases, to live longer, better lives. Verita has a chain of 10 clinics, believes its digital health disease prevention and management platform is about to become the largest in the world and owns IP, and research and manufacturing in Europe, Asia and Australia.

Capio deal turns Ramsay into majority-European-revenue company

Ramsay Health Care, the hospital group spanning Australia, SE Asia and Europe grew revenues 24.4% to US$7.7bn in the year to June 2019 although four-fifths of growth was from the Capio acquisition. Over half of its reported sales now come from Europe, the UK segment has improved while a German divestment is still on the cards.

Icon Group takes second punt at China

Australian oncology provider Icon Group has been proudly talking of its 'first' venture into China through a partnership with the Sanbo Brain Hospital Group. Yet in 2016 it announced a similar deal with Yibai Healthcare that failed to materialise. HBI speaks to CEO Mark Middleton about what's different this time around.

FREE BLOG Is value health dead?

A decade ago value health was flying high. Launched by Harvard guru Michael Porter in 2006 the idea was enthusiastically espoused by Barak Obama and central to Obamacare. Then along came Trump. Meanwhile, the fiendish complexity of health care has stymied efforts. So where is it now? ICHOM 2019 in Rotterdam with 1,250 delegates was a great place to find out.

Wafer-thin health care service profits at Bupa

Why did Bupa, the international health insurer which is also one of the largest health care service players outside of the USA, announce its 2018 results so quietly that HBI isn't aware of any UK daily reporting them this year? The figures show that Bupa's £3.37bn of revenue from nursing homes, hospitals, dentistry and primary care across a dozen countries, barely made money. Could this be down to its interesting governance structure?

Interview: Michael Sandhu, Remedium RT

After a long career at radiotherapy supplier Varian where he ended as Vice President, Global Market Development, Michael has set up his own consultancy to advise governments, international agencies and the private sector on the development of radiation therapy services in general and the best business models.  HBI asks him where the opportunities are and what they look like. 

Find Us